In this episode of On Trial, host Christopher DeGennaro sits down with Foley senior partner Mike Tuteur, former chair of Foley’s national Litigation Department, with 40 years’ experience as a trial lawyer, including as a federal prosecutor in Boston. In addition to offering his thoughts on closing argument and objections, Mike explains his view on the most important skill of a trial lawyer (being resilient), and shares some of his own memorable trial moments.
Listen to the latest On Trial episode below or listen and subscribe on Apple Podcasts, Google Podcasts, Spotify, or Stitcher.
Disclaimer
This podcast is provided for general informational purposes only and is intended as a general overview. The podcast does not constitute legal advice nor solicitation to provide legal services. It is not meant to convey a legal position of Foley & Lardner, LLP (“Foley” or the “Firm”) on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this podcast do not necessarily reflect the views of the Firm, its partners, or its clients. The podcast is not intended to create, and listening to the podcast does not constitute an attorney-client relationship. The listener should not act upon this information without seeking counsel from a licensed attorney. Foley makes no representations or warranties of any kind, express or implied, as to the content of the podcast or to its accuracy or completeness and accepts no responsibility for an individual who acts or refrains from acting based on information obtained from the podcast. In some jurisdictions, the contents of this podcasts may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.
Speaker(s)
Related Insights
07 November 2024
Manufacturing Industry Advisor
What Every Multinational Company Should Know About . . . Dawn Raids
In today’s regulatory landscape, dawn raids — surprise, on-the-spot government inspections — have become increasingly prevalent, especially in Europe, Asia, and South America, where regulatory scrutiny is intensifying.
05 November 2024
Health Care Law Today
Cancer Drugs: Clinical Trial Issues for Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Antibody Drug Conjugates (ADCs) are a class of small molecule drugs and an antibody conjugated together by a chemical linker.
05 November 2024
Health Care Law Today
New HCPCS for Advanced Primary Care Management
The Center for Medicare & Medicaid Services issued the display copy of the final Calendar Year 2025 Physician Fee Schedule on November 1, 2024, which included three new Healthcare Common Procedure Coding System codes for advanced primary care management.